Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
4.270
-0.210 (-4.69%)
Nov 20, 2024, 4:00 PM EST - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $115.16 million as of November 21, 2024.
Market Cap
115.16M
Enterprise Value
-51.05M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.27
Market Cap Chart
Since the IPO on February 2, 2024, Alto Neuroscience's market cap has decreased from $409.04M to $115.16M, a decrease of -71.85%. That is a compound annual growth rate of -79.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 115.16M | -71.85% |
| Feb 2, 2024 | 409.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 128.04M |
| Context Therapeutics | 126.00M |
| Ventyx Biosciences | 125.16M |
| Cibus | 124.48M |
| Zomedica | 124.45M |
| Repare Therapeutics | 123.71M |
| Elutia | 122.96M |
| Protalix BioTherapeutics | 122.08M |